Life Science

India emerging GCC hub for life sciences companies, says EY report

The report, titled Reimagining Life Sciences Global Capability Centres (GCCs), said that life sciences GCCs in India now handle 70 per cent of finance, 75 per cent of HR, 62 per cent of supply chain

Manpower acquisition, retention biggest challenges for R&D GCCs: Expert

GCCs in life sciences and healthcare have grown across India, with Bengaluru, Hyderabad, and Chennai emerging as key hubs

India, UK to enhance bilateral cooperation in healthcare, life sciences

India and the UK have agreed to enhance bilateral cooperation in the field of healthcare and life sciences as strategic partners with strong links in the area, with a specific aim of strengthening collaboration in the health technology and innovation sectors. The Health and Life Sciences Partnership' signed by UK Health Secretary Wes Streeting in London on Thursday will cover a broad range of areas, including digitisation and innovation across the country's state-funded National Health Service (NHS). This will strengthen the UK's partnership of cooperation with India on healthcare innovation and health security, said the UK's Department of Health and Social Care (DHSC). The memorandum of understanding (MoU), signed by Union Minister of Health and Family Welfare Jagat Prakash Nadda at the Delhi end, will also cover joint research, information sharing and cooperation through multilateral fora in areas such as antimicrobial resistance (AMR). The Health and Life Sciences agreement ...

Kotak Alternate Asset raises Rs 250 cr in first close of Life Sciences Fund

The Kotak Life Sciences Fund aims to deploy capital in early- to growth-stage companies across life sciences, including pharmaceuticals, biotechnology, medical devices and digital health

Aragen secures $100 mn funding from Quadria Capital, plans expansion

Contract research, development and manufacturing organisation Aragen on Monday said it has secured USD 100 million investment from private equity fund Quadria Capital. The investment will result in Quadria acquiring a minority stake in Aragen, at a valuation of around USD 1.4 billion, primarily through a fresh capital infusion, with a small portion from the sale of shares by existing investors, the company said in a statement. The funding will support the company's strategic expansion of its capabilities and infrastructure, enabling it to meet the growing demand for outsourcing services from innovators in the US and Europe, it added. With investment, Quadria joins Goldman Sachs as the second strategic investor in Aragen. "This investment marks a pivotal moment as we scale to meet the needs of a rapidly evolving market, said Manni Kantipudi, CEO, Aragen Life Science. "Our expanded capabilities will allow us to support the rising demand for integrated discovery and manufacturing ...

Merck India appoints Dhananjay Singh as MD of its Life Science unit

Over the years, Singh has taken on several leadership roles in commercial organisations such as Sigma-Aldrich and Merck India

Glenmark Life Sciences Q3 profit rises to Rs 119 cr, API biz up 6.4%

The Mumbai-based company, which detergent maker Nirma is in the process of taking over, said its profit rose to 1.19 billion rupees ($14.32 million) in the quarter ended Dec. 31

90% of Indian biz leaders planning to invest more in AI, Gen AI: Capgemini

Capgemini's survey included business leaders from 2,000 organisations in 15 countries across sectors such as automotive, consumer products, banking, capital markets, life sciences, etc

Glenmark Life Sciences Q2 results: PAT rises 11%, revenue up 16.9%

Generic API revenues increased by 19.7 percent this quarter due to growth in US, LATAM and Europe regulated markets

Zydus Lifesciences appoints Punit Patel as president & CEO of Americas

Punit Patel will oversee the business operations of all Zydus entities in North America, including generics, injectables, specialty business, rare and orphan disease portfolio

Cytiva opens new manufacturing facility and experience center in Pune

The newly unveiled manufacturing facility in Pune will produce bioprocessing equipment, including tangential flow, virus filtration, and inactivation systems

Telangana targets $250 bn life sciences ecosystem by 2030: Minister KTR

Aiming to position Hyderabad as the "Health-Tech Mecca" of the world, Telangana Minister for IT and Industries K T Rama Rao on Friday said the government targets to triple the life sciences sector ecosystem in the state to USD 250 billion by 2030 from the existing USD 80 billion. Speaking at the 20th Edition of BioAsia 2023, a three-day life sciences conclave which began here today, KTR said the state is home to over 1,000 life sciences companies globally, including the top 10 pharma firms, in their innovation journey. He said the ecosystem value has already touched USD 80 billion in 2022 which represents a phenomenal ecosystem value growth in Telangana at a mind-boggling 23 per cent over the last two years compared to the national average of about 14 per cent. "We have a unique opportunity to help reshape the future of the life sciences industry. We need to dream big. I envision that by 2030, the value of the life sciences ecosystem will cross USD 250 billion," he said. He further

Nagoya University identifies neurons which maintain body temperature

A group of neurons, called EP3 neurons, in the preoptic area of the brain play a key role in regulating body temperature in mammals, reported a research group at Nagoya University in Japan.

Centre unveils India's first national repository for life science data

India's first national repository for life science data, generated from publicly-funded research in the country, was unveiled here on Thursday by Science and Technology Minister Jitendra Singh. The 'Indian Biological Data Centre' (IBDC), established at the Regional Centre of Biotechnology here, has data storage capacity of four petabytes and is also home to the 'Brahm' High Performance Computing facility. A data disaster recovery site has been set up at the National Informatics Centre, Bhubaneshwar, Singh said. Prof Sudhanshu Vrati, Executive Director of IBDC, said the life sciences data was till now stored in data repositories in Europe and the US, and a need was felt to house the data within the country. The computational infrastructure at IBDC has also been made available for researchers interested in performing computational-intensive analysis. Singh said that IBDC has started nucleotide data submission services via two data portals viz. the 'Indian Nucleotide Data Archive (IN

Infosys to acquire Denmark-based BASE life science for Rs 875 crore

Infosys on Wednesday said it will acquire Denmark-based BASE life science for about 110 million euros (Rs 875 crore) in an all-cash deal. The acquisition will deepen Infosys' expertise in life sciences domain as well as strengthen its footprint across Europe. "This acquisition augments Infosys' deep life sciences expertise, and expands our footprint further in the Nordics region and across Europe, and scales our digital transformation capabilities with cloud-based industry solutions. "We are excited to welcome BASE life science and its leadership team into the Infosys family," Infosys president Ravi Kumar S said. The deal is expected to close during the second quarter of current fiscal. BASE brings to Infosys, domain experts with commercial, medical, digital marketing, clinical, regulatory, and quality knowhow. "Backed by a team of data science specialists, BASE is at the frontier of the latest technological developments and trends. It has a strong focus on Data & AI, and the ...

How the human code has been unraveled: Here's what experts suggest

Last week, scientists completed sequencing the human genome, the goal of a project that began in October 1990

Salary increments in India to touch 5-yr high of 9.9% in 2022: Aon survey

According to leading global professional services firm Aon's 26th Salary Increase Survey in India, organizations across industries project a 9.9% salary increase in 2022, compared to 9.3% in 2021

Tarsons Products IPO subscribed 3.58 times on second day

The Rs 1,023.84-crore IPO received bids for 38,807,802 shares against 10,844,104 shares on offer, according to NSE

Life sciences firm Tarsons Products sets IPO price band at Rs 635-662/share

Leading life sciences company Tarsons Products on Wednesday said it has fixed a price band of Rs 635-662 a share for its Rs 1,024-crore initial share-sale. The three-day initial public offering (IPO) will open on November 15 and conclude on November 17. The bidding for anchor investors will open on November 12, the company announced. The initial share-sale comprises fresh issuance of equity shares worth Rs 150 crore and an offer for sale (OFS) of 1.32 crore equity shares by promoters and an investor. As a part of the OFS, promoters -- Sanjive Sehgal will offload up to 3.9 lakh equity shares and Rohan Sehgal will sell up to 3.1 lakh equity shares -- and investor Clear Vision Investment Holdings Pte Ltd will divest up to 1.25 crore equity shares. At the upper end of the price band, the IPO is expected to fetch Rs 1,024 crore. The public issue will include a reservation of 60,000 equity shares for employees. ICICI Securities, Edelweiss Financial Services and SBI Capital Markets are

Life sciences company Tarsons Products' IPO to open on November 15

The initial share sale of life sciences company Tarsons will open for public subscription on November 15.